Dr. Verdier has a unique breath of regulatory and development experience in vaccines / biologics with truly global experience across multiple regulatory agencies (over 26 years). He led regional and global Regulatory teams and managed development of regulatory strategy from clinical trials to global registrations. Dr. Verdier has a proven track record in successful registrations in various countries (e.g. hexavalent pediatric vaccine, adjuvanted pandemic flu vaccine, Japanese encephalitis vaccine, dengue vaccine, COVID vaccine).

Dr. Verdier served as Senior VP Regulatory Affairs and Clinical Quality for Clover Biopharmaceuticals, a biotechnology company committed to developing novel vaccines. Previously with Sanofi for over 25 years, Dr. Verdier led Regulatory Affairs activities for their COVID and Dengue vaccines, and other products. 

In positions of increasing authority, Dr. Verdier has led cross-functional project teams with Industrial Affairs, Quality and Clinical departments, to achieve fast-track submissions and registrations.  He has led VRBPAC (or equivalent) preparations and managed regulatory teams across the spectrum of R&D from early to late development, for bacterial and viral targets, using numerous platform technologies.